OMEFAS
USPTO Trademark Record · Serial No. 85118309
Trademark details
It was initially claimed by Chrysalis Pharma AG on 20100830.
That brand applies to the following goods and services:Chemicals for use in the manufacture of pharmaceutical preparations and substances for treating diseases, disorders and conditions of the gastro-intestinal tract, namely, Crohn's disease, irritable bowel syndrome and ulcerative colitis, cardiovascular diseases, disorders and conditions, neurological diseases, disorders and conditions, ophthalmic diseases, disorders and conditions, feeding diseases, disorders and conditions, autoimmune diseases, disorders and conditions, inflammatory diseases, di, Pharmaceutical preparations and substances for treating the following: diseases, disorders and conditions of the gastro-intestinal tract, namely, Crohn's disease, irritable bowel syndrome and ulcerative colitis; and pharmaceutical preparations and substances for use in treating cardiovascular diseases, disorders and conditions; neurological diseases, disorders and conditions, ophthalmic diseases, disorders and conditions, feeding diseases, disorders and conditions, autoimmune diseases, disorders.
Currently that trademark is represented by trademark attorney(s): Patrick J. Jennings.
You can learn more about that trademark on the USPTO website: View the USPTO record
Services available
Questions about this trademark?
If you have questions or issues related to the OMEFAS trademark — or to trademarks in general — our trademark attorneys can help. No appointment needed: call us or request a free estimate.
Register a Trademark Get a Free Estimate
